JP2014516087A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014516087A5 JP2014516087A5 JP2014514933A JP2014514933A JP2014516087A5 JP 2014516087 A5 JP2014516087 A5 JP 2014516087A5 JP 2014514933 A JP2014514933 A JP 2014514933A JP 2014514933 A JP2014514933 A JP 2014514933A JP 2014516087 A5 JP2014516087 A5 JP 2014516087A5
- Authority
- JP
- Japan
- Prior art keywords
- tocopherol
- formulation
- butanol
- pentanol
- polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161495672P | 2011-06-10 | 2011-06-10 | |
| US61/495,672 | 2011-06-10 | ||
| PCT/US2012/041950 WO2013036309A2 (en) | 2011-06-10 | 2012-06-11 | Sustained release formulations for delivery of proteins to the eye and methods of preparing same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014516087A JP2014516087A (ja) | 2014-07-07 |
| JP2014516087A5 true JP2014516087A5 (https=) | 2017-07-27 |
| JP6339011B2 JP6339011B2 (ja) | 2018-06-06 |
Family
ID=47832748
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014514933A Active JP6339011B2 (ja) | 2011-06-10 | 2012-06-11 | 眼へのタンパク質の送出のための持続放出性製剤及びその調製方法 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US9814773B2 (https=) |
| EP (1) | EP2717914B1 (https=) |
| JP (1) | JP6339011B2 (https=) |
| KR (1) | KR20140060274A (https=) |
| CN (1) | CN103945865B (https=) |
| AU (1) | AU2012304909B2 (https=) |
| BR (1) | BR112013031685B1 (https=) |
| CA (1) | CA2838289C (https=) |
| CY (1) | CY1122771T1 (https=) |
| DK (1) | DK2717914T3 (https=) |
| ES (1) | ES2761340T3 (https=) |
| HR (1) | HRP20192276T1 (https=) |
| HU (1) | HUE047737T2 (https=) |
| IN (1) | IN2013MN02384A (https=) |
| LT (1) | LT2717914T (https=) |
| MX (1) | MX359119B (https=) |
| PL (1) | PL2717914T3 (https=) |
| PT (1) | PT2717914T (https=) |
| RS (1) | RS60051B1 (https=) |
| SI (1) | SI2717914T1 (https=) |
| SM (1) | SMT202000021T1 (https=) |
| WO (1) | WO2013036309A2 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2902951T3 (es) * | 2013-05-24 | 2022-03-30 | Icon Bioscience Inc | Uso de dexametasona de liberación sostenida en la inflamación después de cirugía de cataratas |
| PL3139914T3 (pl) * | 2014-05-08 | 2023-11-27 | Kiora Pharmaceuticals Gmbh | Związki stosowane w leczeniu chorób i schorzeń okulistycznych |
| TWI731853B (zh) * | 2015-03-18 | 2021-07-01 | 日商參天製藥股份有限公司 | 徐放性醫藥組成物及其安定化方法 |
| EP3318280A4 (en) * | 2015-07-01 | 2018-08-22 | Santen Pharmaceutical Co., Ltd | Depot preparation containing citric acid ester |
| US10786515B2 (en) * | 2015-08-03 | 2020-09-29 | Tolmar International Limited | Liquid polymer delivery system for extended administration of drugs |
| CA2998504C (en) | 2015-09-21 | 2023-06-20 | Teva Pharmaceuticals International Gmbh | Sustained release olanzapine formulations |
| WO2018172850A1 (en) | 2017-03-20 | 2018-09-27 | Teva Pharmaceuticals International Gmbh | Sustained release olanzapine formulaitons |
| KR101957599B1 (ko) | 2017-10-23 | 2019-03-13 | 김상현 | 훈제 단무지 제조 방법, 이에 의해 제조된 훈제 단무지 |
| JP7394770B2 (ja) | 2018-02-09 | 2023-12-08 | アイコン バイオサイエンス，インコーポレイテッド | 注射器から少量の用量を装填および送達するためのシステム、キット、および方法 |
| AU2019263302C1 (en) | 2018-05-01 | 2024-10-31 | Chibi, Inc. | Liquid depot for non-invasive sustained delivery of agents to the eye |
| CN112423740A (zh) | 2018-05-01 | 2021-02-26 | 奇比有限公司 | 用于将药物持续递送至视网膜的滴眼剂制剂和方法 |
| JP2023526512A (ja) * | 2020-05-22 | 2023-06-21 | トラスティーズ オブ ボストン ユニバーシティ | 線維化疾患を処置するための方法および組成物 |
| US20240100012A1 (en) | 2021-01-18 | 2024-03-28 | Mark Hasleton | Pharmaceutical dosage form |
| CA3227324A1 (en) | 2021-07-06 | 2023-01-12 | Mark Hasleton | Treatment of serotonin reuptake inhibitor withdrawal syndrome |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2658432B1 (fr) * | 1990-02-22 | 1994-07-01 | Medgenix Group Sa | Microspheres pour la liberation controlee des substances hydrosolubles et procede de preparation. |
| WO2002000137A1 (en) * | 2000-06-28 | 2002-01-03 | Shukla Atul J | Biodegradable vehicles and delivery systems of biologically active substances |
| US20040001889A1 (en) * | 2002-06-25 | 2004-01-01 | Guohua Chen | Short duration depot formulations |
| TWI353854B (en) * | 2002-06-25 | 2011-12-11 | Alza Corp | Short duration depot formulations |
| MXPA05013003A (es) * | 2003-05-30 | 2006-03-17 | Alza Corp | Composiciones de deposito elastomerico implantables, usos de las mismas y metodo para elaboracion. |
| US7727969B2 (en) * | 2003-06-06 | 2010-06-01 | Massachusetts Institute Of Technology | Controlled release nanoparticle having bound oligonucleotide for targeted delivery |
| US8685435B2 (en) * | 2004-04-30 | 2014-04-01 | Allergan, Inc. | Extended release biodegradable ocular implants |
| WO2005110374A1 (en) * | 2004-04-30 | 2005-11-24 | Allergan, Inc. | Intraocular drug delivery systems containing a therapeutic component, a cyclodextrin, and a polymeric component |
| US7771742B2 (en) * | 2004-04-30 | 2010-08-10 | Allergan, Inc. | Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods |
| EP2452670A1 (en) * | 2004-10-01 | 2012-05-16 | Ramscor, Inc. | Conveniently implantable sustained release drug compositions |
| US20080038316A1 (en) | 2004-10-01 | 2008-02-14 | Wong Vernon G | Conveniently implantable sustained release drug compositions |
| BRPI0516308A2 (pt) * | 2004-10-04 | 2010-06-15 | Qlt Usa Inc | composição fluida, métodos de tratamento de uma doença ou disfunção, métodos de liberação local ou sistêmica de um agente biológico, implantes, método de formação de um implante, kit de agente biológico e usos de uma composição fluida |
| US8039010B2 (en) | 2006-11-03 | 2011-10-18 | Allergan, Inc. | Sustained release intraocular drug delivery systems comprising a water soluble therapeutic agent and a release modifier |
| US8969415B2 (en) * | 2006-12-01 | 2015-03-03 | Allergan, Inc. | Intraocular drug delivery systems |
| US8821870B2 (en) * | 2008-07-18 | 2014-09-02 | Allergan, Inc. | Method for treating atrophic age related macular degeneration |
| WO2010105093A2 (en) * | 2009-03-12 | 2010-09-16 | Delpor, Inc. | Implantable device for long-term delivery of drugs |
| EP2269663B1 (en) * | 2009-07-03 | 2018-03-07 | Armbruster Biotechnology GmbH | Bone graft and biocomposite |
-
2012
- 2012-06-11 HU HUE12829655A patent/HUE047737T2/hu unknown
- 2012-06-11 KR KR1020147000443A patent/KR20140060274A/ko not_active Withdrawn
- 2012-06-11 HR HRP20192276TT patent/HRP20192276T1/hr unknown
- 2012-06-11 PT PT128296555T patent/PT2717914T/pt unknown
- 2012-06-11 CA CA2838289A patent/CA2838289C/en active Active
- 2012-06-11 BR BR112013031685-3A patent/BR112013031685B1/pt active IP Right Grant
- 2012-06-11 SI SI201231706T patent/SI2717914T1/sl unknown
- 2012-06-11 SM SM20200021T patent/SMT202000021T1/it unknown
- 2012-06-11 ES ES12829655T patent/ES2761340T3/es active Active
- 2012-06-11 AU AU2012304909A patent/AU2012304909B2/en active Active
- 2012-06-11 MX MX2013014461A patent/MX359119B/es active IP Right Grant
- 2012-06-11 CN CN201280028816.4A patent/CN103945865B/zh active Active
- 2012-06-11 WO PCT/US2012/041950 patent/WO2013036309A2/en not_active Ceased
- 2012-06-11 JP JP2014514933A patent/JP6339011B2/ja active Active
- 2012-06-11 RS RS20191574A patent/RS60051B1/sr unknown
- 2012-06-11 IN IN2384MUN2013 patent/IN2013MN02384A/en unknown
- 2012-06-11 EP EP12829655.5A patent/EP2717914B1/en active Active
- 2012-06-11 US US14/124,631 patent/US9814773B2/en active Active
- 2012-06-11 PL PL12829655T patent/PL2717914T3/pl unknown
- 2012-06-11 LT LTEP12829655.5T patent/LT2717914T/lt unknown
- 2012-06-11 DK DK12829655.5T patent/DK2717914T3/da active
-
2020
- 2020-01-17 CY CY20201100042T patent/CY1122771T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014516087A5 (https=) | ||
| KR101341359B1 (ko) | 편리하게 이식가능한 서방형 약물 조성물 | |
| JP6416154B2 (ja) | 眼房内ビマトプロスト注入物による眼圧低下 | |
| US9011915B2 (en) | Conveniently implantable sustained release drug compositions | |
| Heller | Ocular delivery using poly (ortho esters) | |
| CN107184544A (zh) | 前房内持续释放治疗药植入物 | |
| JP6339011B2 (ja) | 眼へのタンパク質の送出のための持続放出性製剤及びその調製方法 | |
| CA2993340C (en) | Intravitreal drug delivery systems for the treatment of ocular conditions | |
| KR20160100992A (ko) | 눈의 병태의 치료를 위한 전방내 이식물 | |
| CN109602691A (zh) | 持续药物递送植入物 | |
| WO2015135306A1 (zh) | 青蒿素及其衍生物在制备防治眼科血管性疾病药物中的应用及药物组合物 | |
| Einmahl et al. | Ocular biocompatibility of a poly (ortho ester) characterized by autocatalyzed degradation | |
| CN114533648A (zh) | 一种阿西替尼眼内植入剂 | |
| Jelonek et al. | Polyesters and polyester carbonates for controlled drug delivery. Part II. Implantable systems | |
| Chiang et al. | Suprachoroidal drug delivery for VEGF suppression in wet AMD and other diseases with choroidal neovascularization | |
| KR102191180B1 (ko) | 안질환 치료용 조성물 | |
| KR102183669B1 (ko) | 이중 약물 방출을 위한 약물 전달체 | |
| Augustin et al. | Suprachoroidal drug delivery–a new approach for the treatment of severe macular diseases | |
| CN102406627B (zh) | 一种层层组装马赛克结构药物缓释植片 | |
| CN105496947A (zh) | 一种药物缓释制剂 | |
| CN1846700A (zh) | 5－氟尿嘧啶玻璃体腔缓释系统 | |
| HK1107672B (en) | Conveniently implantable sustained release drug compositions |